Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuronetics (STIM) Gains from Investment Securities (2016 - 2025)

Neuronetics (STIM) has disclosed Gains from Investment Securities for 10 consecutive years, with -$2000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Gains from Investment Securities fell 100.29% to -$2000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $194000.0, a 72.29% decrease, with the full-year FY2024 number at $1.2 million, down 2.6% from a year prior.
  • Gains from Investment Securities was -$2000.0 for Q3 2025 at Neuronetics, down from $4.1 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $6.5 million in Q1 2021 to a low of -$2000.0 in Q3 2025.
  • A 5-year average of $1.1 million and a median of $550000.0 in 2023 define the central range for Gains from Investment Securities.
  • Peak YoY movement for Gains from Investment Securities: surged 9900.0% in 2023, then tumbled 100.29% in 2025.
  • Neuronetics' Gains from Investment Securities stood at $100000.0 in 2021, then changed by 0.0% to $100000.0 in 2022, then surged by 1170.0% to $1.3 million in 2023, then decreased by 2.6% to $1.2 million in 2024, then tumbled by 100.16% to -$2000.0 in 2025.
  • Per Business Quant, the three most recent readings for STIM's Gains from Investment Securities are -$2000.0 (Q3 2025), $4.1 million (Q1 2025), and $1.2 million (Q4 2024).